Jesus Fernandez-Gomez

Summary

Country: Spain

Publications

  1. doi request reprint [Significance of anemia as an independent prognostic factor in patients with renal cell carcinoma]
    Jesús María Fernández Gómez
    Hospital Universitario Central de Austurias, Universidad de Oviedo, Oviedo, Espana
    Med Clin (Barc) 133:407-13. 2009
  2. ncbi request reprint Urinary CYFRA 21.1 is not a useful marker for the detection of recurrences in the follow-up of superficial bladder cancer
    Jesus Fernandez-Gomez
    Department of Urology, Hospital Central of Asturias, University of Oviedo, C Celestino Villamil S N, 33006 Oviedo, Asturias, Spain
    Eur Urol 51:1267-74. 2007
  3. ncbi request reprint Prognostic factors in patients with non-muscle-invasive bladder cancer treated with bacillus Calmette-Guérin: multivariate analysis of data from four randomized CUETO trials
    Jesus Fernandez-Gomez
    Department of Urology, Hospital Central of Asturias, University of Oviedo, Oviedo, Spain
    Eur Urol 53:992-1001. 2008
  4. ncbi request reprint [Effectiveness of bisphosphonates in advanced prostate cancer]
    Jesus M Fernández Gómez
    European Board of Urology, Universidad de Oviedo, Oviedo, Asturias, Espana
    Med Clin (Barc) 130:459-62. 2008
  5. doi request reprint Sympathetic skin response in patients with erectile dysfunction
    Consuelo Valles-Antuña
    Urology, Hospital Universitario Central de Asturias, Oviedo, Spain
    BJU Int 104:1709-12. 2009
  6. doi request reprint Predicting nonmuscle invasive bladder cancer recurrence and progression in patients treated with bacillus Calmette-Guerin: the CUETO scoring model
    Jesus Fernandez-Gomez
    Department of Urology, Hospital Central of Asturias, University of Oviedo, Oviedo, Spain
    J Urol 182:2195-203. 2009
  7. doi request reprint The EORTC tables overestimate the risk of recurrence and progression in patients with non-muscle-invasive bladder cancer treated with bacillus Calmette-Guérin: external validation of the EORTC risk tables
    Jesus Fernandez-Gomez
    Department of Urology, Hospital Central of Asturias, University of Oviedo, Oviedo, Spain
    Eur Urol 60:423-30. 2011
  8. doi request reprint Peripheral neuropathy: an underdiagnosed cause of erectile dysfunction
    Consuelo Valles-Antuña
    Department of Neurophysiology, Hospital Universitario Central de Asturias, Oviedo, Spain
    BJU Int 108:1855-9. 2011
  9. doi request reprint Relationship between metalloprotease expression in tumour and stromal cells and aggressive behaviour in prostate carcinoma: Simultaneous high-throughput study of multiple metalloproteases and their inhibitors using tissue array analysis of radical prostat
    Jesus Fernandez-Gomez
    Department of Urology, Hospital Central de Asturias, Oviedo, Spain
    Scand J Urol Nephrol 45:171-6. 2011
  10. ncbi request reprint Telomere length on bladder washing samples from patients with bladder cancer correlates with tumor characteristics flow cytometry method for quantitative fluorescence in situ hybridization (flow-FISH technique)
    Jesus Fernandez-Gomez
    Department of Urology, Hospital Central of Asturias, University of Oviedo, Asturias, Spain
    Eur Urol 48:432-7. 2005

Collaborators

Detail Information

Publications10

  1. doi request reprint [Significance of anemia as an independent prognostic factor in patients with renal cell carcinoma]
    Jesús María Fernández Gómez
    Hospital Universitario Central de Austurias, Universidad de Oviedo, Oviedo, Espana
    Med Clin (Barc) 133:407-13. 2009
    ..The aim of this study was to analyze the significance of anemia as well as other prognostic factors influencing survival in patients with renal cell carcinoma (RCC)...
  2. ncbi request reprint Urinary CYFRA 21.1 is not a useful marker for the detection of recurrences in the follow-up of superficial bladder cancer
    Jesus Fernandez-Gomez
    Department of Urology, Hospital Central of Asturias, University of Oviedo, C Celestino Villamil S N, 33006 Oviedo, Asturias, Spain
    Eur Urol 51:1267-74. 2007
    ..1 assay and to assess its utility combined with voided cytology and/or haemoglobin dipstick in the follow-up of patients with superficial bladder cancer...
  3. ncbi request reprint Prognostic factors in patients with non-muscle-invasive bladder cancer treated with bacillus Calmette-Guérin: multivariate analysis of data from four randomized CUETO trials
    Jesus Fernandez-Gomez
    Department of Urology, Hospital Central of Asturias, University of Oviedo, Oviedo, Spain
    Eur Urol 53:992-1001. 2008
    ..To evaluate the prognostic factors of recurrence and progression after intravesical adjuvant bacillus Calmette-Guérin (BCG) immunotherapy in patients with non-muscle-invasive bladder tumors...
  4. ncbi request reprint [Effectiveness of bisphosphonates in advanced prostate cancer]
    Jesus M Fernández Gómez
    European Board of Urology, Universidad de Oviedo, Oviedo, Asturias, Espana
    Med Clin (Barc) 130:459-62. 2008
  5. doi request reprint Sympathetic skin response in patients with erectile dysfunction
    Consuelo Valles-Antuña
    Urology, Hospital Universitario Central de Asturias, Oviedo, Spain
    BJU Int 104:1709-12. 2009
    ..To evaluate the role of the sympathetic skin response (SSR) in men with erectile dysfunction (ED), focusing on detecting SSR in the penis...
  6. doi request reprint Predicting nonmuscle invasive bladder cancer recurrence and progression in patients treated with bacillus Calmette-Guerin: the CUETO scoring model
    Jesus Fernandez-Gomez
    Department of Urology, Hospital Central of Asturias, University of Oviedo, Oviedo, Spain
    J Urol 182:2195-203. 2009
    ..However, in that series only 171 patients were treated with bacillus Calmette-Guerin. We developed a risk stratification model to provide accurate estimates of recurrence and progression probability after bacillus Calmette-Guerin...
  7. doi request reprint The EORTC tables overestimate the risk of recurrence and progression in patients with non-muscle-invasive bladder cancer treated with bacillus Calmette-Guérin: external validation of the EORTC risk tables
    Jesus Fernandez-Gomez
    Department of Urology, Hospital Central of Asturias, University of Oviedo, Oviedo, Spain
    Eur Urol 60:423-30. 2011
    ..European Organization for Research and Treatment of Cancer (EORTC) risk tables only included 171 patients treated with bacillus Calmette-Guérin (BCG) for non-muscle-invasive bladder cancer (NMIBC)...
  8. doi request reprint Peripheral neuropathy: an underdiagnosed cause of erectile dysfunction
    Consuelo Valles-Antuña
    Department of Neurophysiology, Hospital Universitario Central de Asturias, Oviedo, Spain
    BJU Int 108:1855-9. 2011
    ....
  9. doi request reprint Relationship between metalloprotease expression in tumour and stromal cells and aggressive behaviour in prostate carcinoma: Simultaneous high-throughput study of multiple metalloproteases and their inhibitors using tissue array analysis of radical prostat
    Jesus Fernandez-Gomez
    Department of Urology, Hospital Central de Asturias, Oviedo, Spain
    Scand J Urol Nephrol 45:171-6. 2011
    ..The aim of this study was to detect a potential association between clinicopathological factors of prostate cancer aggressiveness and the expression of matrix metalloproteases and their inhibitors in tumour and stromal cells...
  10. ncbi request reprint Telomere length on bladder washing samples from patients with bladder cancer correlates with tumor characteristics flow cytometry method for quantitative fluorescence in situ hybridization (flow-FISH technique)
    Jesus Fernandez-Gomez
    Department of Urology, Hospital Central of Asturias, University of Oviedo, Asturias, Spain
    Eur Urol 48:432-7. 2005
    ..The purpose of the present study was to evaluate the length of telomeres in patients with bladder cancer using a quantitative flow cytometry (flow-FISH) technique...